Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (341-350 of 676) with videos related to

Pageof 68
Sort By:
Quality & Safety in Health Care|December 10, 2008
Assessment of the implementation of a national patient safety alert to reduce wrong site surgeryP Rhodes, S J Giles, G A Cook, et al.
Quality & Safety in Health Care|November 1, 2006
Experience of wrong site surgery and surgical marking practices among clinicians in the UKSally J Giles, Penny Rhodes, Gill Clements, et al.
Leukemia Research|July 21, 2007
A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disordersJudith E Karp, Francis J Giles, Ivana Gojo, et al.
Leukemia|May 15, 2007
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1J Pan, A Quintás-Cardama, T Manshouri, et al.
Nucleic Acids Research|April 19, 2007
Mapping translocation breakpoints using a wheat microarrayPrasanna R Bhat, Adam Lukaszewski, Xinping Cui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experienceA-M Tsimberidou, F J Giles, I Khouri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemiaS M O'Brien, H M Kantarjian, J Cortes, et al.
Leukemia Research|May 10, 2006
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cellsSrdan Verstovsek, Francis J Giles, Alfonso Quintás-Cardama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutationSrdan Verstovsek, Taghi Manshouri, Alfonso Quintás-Cardama, et al.
Leukemia Research|January 18, 2003
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemiaEfrosyni Apostolidou, Elihu Estey, Jorge Cortes, et al.
Pageof 68

Showing results (341-350 of 676) with videos related to

Sort By:
Pageof 68
Quality & Safety in Health Care|December 10, 2008
Assessment of the implementation of a national patient safety alert to reduce wrong site surgeryP Rhodes, S J Giles, G A Cook, et al.
Quality & Safety in Health Care|November 1, 2006
Experience of wrong site surgery and surgical marking practices among clinicians in the UKSally J Giles, Penny Rhodes, Gill Clements, et al.
Leukemia Research|July 21, 2007
A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disordersJudith E Karp, Francis J Giles, Ivana Gojo, et al.
Leukemia|May 15, 2007
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1J Pan, A Quintás-Cardama, T Manshouri, et al.
Nucleic Acids Research|April 19, 2007
Mapping translocation breakpoints using a wheat microarrayPrasanna R Bhat, Adam Lukaszewski, Xinping Cui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experienceA-M Tsimberidou, F J Giles, I Khouri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemiaS M O'Brien, H M Kantarjian, J Cortes, et al.
Leukemia Research|May 10, 2006
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cellsSrdan Verstovsek, Francis J Giles, Alfonso Quintás-Cardama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutationSrdan Verstovsek, Taghi Manshouri, Alfonso Quintás-Cardama, et al.
Leukemia Research|January 18, 2003
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemiaEfrosyni Apostolidou, Elihu Estey, Jorge Cortes, et al.
Pageof 68